← Back to Search

Silver-based Dressing

Intervention for Foot Ulcer

N/A
Waitlist Available
Research Sponsored by Exciton Technologies Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Correction or optimization of underlying medical problems (e.g. diabetes or systemic infection).
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 48-72 hours of first intervention application
Awards & highlights

Study Summary

This trialinvestigates if a silver gel can safely and effectively improve healing of diabetic foot ulcers when standard care fails.

Eligible Conditions
  • Foot Ulcer
  • Diabetic Foot Ulcer
  • Diabetic Foot Infection

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You need to address and improve any existing medical conditions, such as diabetes or infections, before participating in the trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 48-72 hours of first intervention application
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 48-72 hours of first intervention application for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of intervention-related adverse events collected throughout the trial
Secondary outcome measures
Early clinical response
Number of participants with systemic antibiotic or antifungal drug administration over the course of the intervention versus screening and baseline.
Percent change in wound area and volume during the intervention period compared to baseline.
+17 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
A prospective, single-arm, repeated measures feasibility study will be coordinated on the use of EPC Silver Wound Gel in patients with diabetic foot ulcers and localized infections within an outpatient clinical setting, to determine the safety of EPC Silver Wound Gel on diabetic foot ulcerations and impact on wound infection classification, wound ecology, and immunological biomarkers, in conjunction with the standard of care, to clarify parameters for a potential future study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EPC Silver Wound Gel
2022
N/A
~10

Find a Location

Who is running the clinical trial?

Exciton Technologies Inc.Lead Sponsor
3 Previous Clinical Trials
42 Total Patients Enrolled
1 Trials studying Foot Ulcer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still underway for this research project?

"Affirmative, according to clinicaltrials.gov the medical trial is presently recruiting individuals. It first appeared on November 28th 2022 and was edited for the last time on January 9th 2023. Five patients will be enrolled from a single site."

Answered by AI

How many participants are being administered the treatment in this experiment?

"Yes, current information hosted on clinicaltrials.gov confirms that this medical study is currently seeking patients. It was initially posted on 28th November 2022 and the most recent update was made on 9th January 2023. The trial requires 5 participants to be recruited from one site."

Answered by AI
~2 spots leftby Mar 2025